Neuroleptic malignant syndrome in COVID-19 patients by Soh et al

被引：0
|
作者：
Ubhayakar, Nitin [1 ]
Liu, Antonio [1 ]
机构：
[1] Adventist Hlth White Mem, Los Angeles, CA 90033 USA
来源：
AMERICAN JOURNAL OF EMERGENCY MEDICINE | 2021年 / 43卷
关键词：
D O I：
10.1016/j.ajem.2020.06.038
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：259 / 259
页数：1
相关论文
共 50 条
  • [31] THE ASSOCIATION BETWEEN COVID-19 INFECTION AND DISEASE FLARES IN PATIENTS WITH BEHÇET'S SYNDROME
    Zheng, W.
    Liu, Y.
    Wang, Z.
    Yu, X.
    Liu, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83
  • [32] Recovery and rehabilitation of patients with COVID-19 and post-COVID-19 syndrome
    Kasnakova, Petya
    Kilova, Kristina
    KUWAIT MEDICAL JOURNAL, 2021, 53 (03): : 346 - 347
  • [33] Response to: 'Comment on Ye et al 'Presence of respiratory failure of COVID-19 infection in patients with rheumatism in Wuhan, China'' by Chen et al
    Zhong, Jixin
    Ye, Cong
    Cai, Shaozhe
    Dong, Lingli
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (08)
  • [34] A FOLLOW-UP OF PATIENTS WITH NEUROLEPTIC MALIGNANT SYNDROME
    CHEN, CC
    REIST, C
    KO, WK
    HOSPITAL AND COMMUNITY PSYCHIATRY, 1991, 42 (02): : 197 - 199
  • [35] Neuroleptic malignant syndrome in patients with cancer: a systematic review
    Sato, Izumi
    Onishi, Hideki
    Kawanishi, Chiaki
    Yamada, Shuhei
    Ishida, Mayumi
    Kawakami, Koji
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2020, 10 (03) : 265 - 270
  • [36] Risk of neuroleptic malignant syndrome in patients with NMDAR encephalitis
    Stanley N. Caroff
    E. Cabrina Campbell
    Neurological Sciences, 2015, 36 : 479 - 480
  • [37] RISK OF MALIGNANT HYPERTHERMIA AMONG PATIENTS WITH NEUROLEPTIC MALIGNANT SYNDROME AND THEIR FAMILIES
    HERMESH, H
    AIZENBERG, D
    LAPIDOT, M
    MUNITZ, H
    AMERICAN JOURNAL OF PSYCHIATRY, 1988, 145 (11): : 1431 - 1434
  • [38] Risk of neuroleptic malignant syndrome in patients with NMDAR encephalitis
    Caroff, Stanley N.
    Campbell, E. Cabrina
    NEUROLOGICAL SCIENCES, 2015, 36 (03) : 479 - 480
  • [39] Neuroleptic malignant syndrome in parkinsonian patients: Risk factors
    Kuno, S
    Mizuta, E
    Yamasaki, S
    EUROPEAN NEUROLOGY, 1997, 38 : 56 - 59
  • [40] Response to: 'COVID-19 in patients with rheumatic diseases: what is the real mortality risk?' by Marques et al
    D'Silva, Kristin M.
    Serling-Boyd, Naomi
    Wallwork, Rachel
    Hsu, Tiffany Y-T
    Sparks, Jeffrey A.
    Wallace, Zachary Scott
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (08)
12345